New Strong Buy Stocks for September 12th
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Cumberland Pharmaceuticals Inc. (CPIX): This specialty pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 8.1% over the last 60 days.
Cumberland Pharmaceuticals Inc. Price and Consensus
Cumberland Pharmaceuticals Inc. price-consensus-chart | Cumberland Pharmaceuticals Inc. Quote
Quanex Building Products Corporation (NX): This company that provides components for the fenestration industry has seen the Zacks Consensus Estimate for its current year earnings increasing 9.4% over the last 60 days.
Quanex Building Products Corporation Price and Consensus
Quanex Building Products Corporation price-consensus-chart | Quanex Building Products Corporation Quote
Albany International Corp. (AIN): This company that engages in the textile and materials processing businesses has seen the Zacks Consensus Estimate for its current year earnings increasing 2.7% over the last 60 days.
Albany International Corporation Price and Consensus
Albany International Corporation price-consensus-chart | Albany International Corporation Quote
ChannelAdvisor Corporation (ECOM): This company that provides software-as-a-service solutions has seen the Zacks Consensus Estimate for its current year earnings increasing 30.3% over the last 60 days.
ChannelAdvisor Corporation Price and Consensus
ChannelAdvisor Corporation price-consensus-chart | ChannelAdvisor Corporation Quote
Meta Financial Group, Inc. (CASH): This company that offers various banking products and services has seen the Zacks Consensus Estimate for its current year earnings increasing 12.7% over the last 60 days.
Meta Financial Group, Inc. Price and Consensus
Meta Financial Group, Inc. price-consensus-chart | Meta Financial Group, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Quanex Building Products Corporation (NX) : Free Stock Analysis Report
ChannelAdvisor Corporation (ECOM) : Free Stock Analysis Report
Cumberland Pharmaceuticals Inc. (CPIX) : Free Stock Analysis Report
Meta Financial Group, Inc. (CASH) : Free Stock Analysis Report
Albany International Corporation (AIN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research